Potential Off‐Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild‐Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms.
Saved in:
| Title: | Potential Off‐Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild‐Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms. |
|---|---|
| Authors: | Chang, Shuting1 (AUTHOR), Pan, Zhijuan1 (AUTHOR), Zhang, Yiqun1 (AUTHOR), Zhang, Ying1 (AUTHOR), Sun, Jiajia1 (AUTHOR), Guo, Yanru1 (AUTHOR), Guo, Xinlei1 (AUTHOR), Guo, Zhiping1 (AUTHOR) guozhiping7830@163.com, Reikvam, Ha Kon1 (AUTHOR) hakon.reikvam@uib.no |
| Source: | Case Reports in Hematology. 10/29/2025, Vol. 2025, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20906560 |
|---|---|
| DOI: | 10.1155/crh/4335095 |
